Synvisc and Hyalgan are both brand-name drugs used in viscosupplementation to treat osteoarthritis knee pain by cushioning the joint and improving mobility. Both Synvisc and Hyalgan are made from ...
What Are Hyalgan and Synvisc? Hyaluronic acid is a natural, gel-like substance in your joints. It cushions and lubricates your joints as you move them. If you develop OA, cartilage in your joint ...
Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...
Synvisc-One (hylan G-F 20, from Genzyme), has been FDAapproved for the relief of pain associated with osteoarthritis (OA) of the kneein patients who have failed to respond adequately to ...
Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted marketing approval to Genzyme Corp. for its Synvisc-One product indicated for the relief of ...
Hylan G-F 20 (hylan A and hylan B) 48mg; per 6mL; soln for intra-articular inj. Avian protein, feathers, or egg allergy. Severely inflamed knee joints. Lymphatic or venous stasis in leg. Advise ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Cambridge-based Genzyme Corp., a subsidiary of French drug ...
Important Therapy Provides Six Months Pain Relief with Single Injection Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results